Cooley L, Dendle C, Wolf J, et al. Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies. Intern Med J. 2014;44:1350–63.

Article  CAS  PubMed  Google Scholar 

Xixia C, Xiaoming S, Linrong H, et al. High prevalence and mortality of Pneumocystis jirovecii pneumonia in anti-MDA5 antibody- positive dermatomyositis. Rheumatology. 2023; 62:3302–9.

Article  Google Scholar 

Alanio A, Hauser PM, Lagrou K, Melchers WJ, Helweg-Larsen J, Matos O, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Cordonnier C, Maertens J, Bretagne S, 5th European Conference on Infections in Leukemia (ECIL-5), a joint venture of The European Group for Blood and Marrow Transplantation (EBMT), The European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and The European LeukemiaNet (ELN). ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71:2386–96.

Article  CAS  PubMed  Google Scholar 

Fillatre P, Decaux O, Jouneau S, Revest M, Gacouin A, Robert-Gangneux F, et al. Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients. Am J Med. 2014;127:1242e11-1243e17.

Article  Google Scholar 

Festic E, Gajic O, Limper AH, Aksamit TR. Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features. Chest. 2005;128:573–539.

Article  PubMed  Google Scholar 

Maini R, Henderson KL, Sheridan EA, et al. Increasing Pneumocystis pneumonia, England, UK, 2000–2010. Emerg Infect Dis. 2013;19:386–92.

Article  PubMed  PubMed Central  Google Scholar 

Vidal S, de la Horra C, Martín J, et al. Pneumocystis jirovecii colonisation in patients with interstitial lung disease. Clin Microbiol Infect. 2006;12:231–5.

Article  CAS  PubMed  Google Scholar 

Hamada S, Ichiyasu H, Inaba M, Takahashi H, Sadamatsu T, Akaike K, Masunaga A, Tashiro Y, Hirata N, Yoshinaga T, Sakagami T. Prognostic impact of pre-existing interstitial lung disease in non-HIV patients with Pneumocystis pneumonia. ERJ Open Res. 2020;6:00306–2019.

Article  PubMed  PubMed Central  Google Scholar 

Montesi SB, Fisher JH, Martinez FJ, et al. Update in interstitial lung disease 2019. Am J Respir Crit Care Med. 2020;202:500–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rego de Figueiredo I, Vieira Alves R, Drummond Borges D, et al. Pneumocystosis pneumonia: a comparison study between HIV and non-HIV immunocompromised patients. Pulmonology. 2019;25:271–4.

Article  CAS  PubMed  Google Scholar 

Yuxin S, Chi S, Hui H, et al. Prognostic analysis of Pneumocystis jirovecii pneumonia in interstitial lung disease patients: a retrospective clinical study. Diagnostics. 2022;12:2925.

Article  Google Scholar 

Sokulska M, Kicia M, Wesołowska M, Hendrich AB. Pneumocystis jirovecii–from a commensal to pathogen: clinical and diagnostic review. Parasitol Res. 2015;114:3577–85.

Article  PubMed  PubMed Central  Google Scholar 

Wang J, Han Y, Feng J. Metagenomic next-generation sequencing for mixed pulmonary infection diagnosis. BMC Pulm Med. 2019;19:252.

Article  PubMed  PubMed Central  Google Scholar 

Xie Y, Du J, Jin W, et al. Next generation sequencing for diagnosis of severe Pneumonia: China, 2010–2018. J Infect. 2019;78:158–69.

Article  PubMed  Google Scholar 

Liu N, Kan J, Yu N, Cao W, Cao J, Jiang E, Feng J. Application of metagenomic next-generation sequencing technology for difficult lung lesions in patients with haematological diseases. Transl Cancer Res. 2020;9:5245–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, He T, Li X, Wang X, Peng L, Ma L. Metagenomic next-generation sequencing in diagnosis of a case of Pneumocystis jirovecii pneumonia in a kidney transplant recipient and literature review. Infect Drug Resist. 2020;13:2829–36.

Article  PubMed  PubMed Central  Google Scholar 

Anan K, Oshima Y, Ogura T, Tanabe Y, Higashi A, Iwashita Y, Fujita K, Yoshida T, Ando K, Okamori S, Okada Y. Safety and harms of bronchoalveolar lavage for acute respiratory failure: a systematic review and meta-analysis. Respir Investig. 2022;60:68–81.

Article  PubMed  Google Scholar 

Esteves F, Cale SS, Badura R, et al. Diagnosis of Pneumocystis pneumonia: evaluation of four serologic biomarkers. Clin Microbiol Infect. 2015;21:e110-379.e10.

Article  Google Scholar 

Shimizu Y, Sunaga N, Dobashi K, et al. Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study. BMC Infect Dis. 2009;9:47.

Article  PubMed  PubMed Central  Google Scholar 

Damiani C, Le Gal S, Da Costa C, Virmaux M, Nevez G, Totet A. Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of Pneumocystis pneumonia and Pneumocystis colonization. J Clin Microbiol. 2013;51:3380–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

White PL, Backx M, Barnes RA. Diagnosis and management of Pneumocystis jirovecii infection. Expert Rev Anti Infect Ther. 2017;15:435–47.

Article  CAS  PubMed  Google Scholar 

Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788–824.

Article  PubMed  PubMed Central  Google Scholar 

Wissmann G, Morilla R, Friaza V, Calderón E, Varela JM. El ser humano como reservorio de Pneumocystis [Human reservoirs of Pneumocystis]. Enferm Infecc Microbiol Clin. 2010;28:38–43.

Article  PubMed  Google Scholar 

Tasaka S, Tokuda H. Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies. J Infect Chemother. 2012;18:793–806.

Article  CAS  PubMed  Google Scholar 

Chen H, Tan C, Wang Z, Zha J, Liu H, Dong Z, Chen G. Long-term glucocorticoid exposure persistently impairs CD4+ T cell biology by epigenetically modulating the mTORC1 pathway. Biochem Pharmacol. 2023;211: 115503.

Article  CAS  PubMed  Google Scholar 

Yamaguchi T, Nagai Y, Morita T, et al. Pneumocystis pneumonia in patients treated with long-term steroid therapy for symptom palliation: a neglected infection in palliative care. Am J Hosp Palliat Care. 2014;31:857–61.

Article  PubMed  Google Scholar 

Plakke MJ, Jalota L, Lloyd BJ. Pneumocystis pneumonia in a non-HIV patient on chronic corticosteroid therapy: a question of prophylaxis. BMJ Case Rep. 2013; 2013: bcr2012007912.

Article  PubMed  PubMed Central  Google Scholar 

Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc. 1996;71:5–13.

Article  CAS  PubMed  Google Scholar 

Green H, Paul M, Vidal L, Leibovici L. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc. 2007;82:1052–9.

Article  CAS  PubMed  Google Scholar 

Messiaen PE, Cuyx S, Dejagere T, van der Hilst JC. The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus-negative immunocompromised patients: a systematic review. Transpl Infect Dis. 2017;19:66.

Article  Google Scholar 

Huang L, Xu S, Huang Z, Chen Y, Xu N, Xie B. Risk factors associated with Pneumocystis jirovecii pneumonia in non-HIV immunocompromised patients and co-pathogens analysis by metagenomic next-generation sequencing. BMC Pulm Med. 2023;23:72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Ghannoum M, Deng C, Gao Y, Zhu H, Yu X, Lavergne V. Pneumocystis pneumonia in patients with inflammatory or autoimmune diseases: usefulness of lymphocyte subtyping. Int J Infect Dis. 2017;57:108–15.

Article  PubMed  Google Scholar 

Mori S, Sugimoto M. Pneumocystis jirovecii pneumonia in rheumatoid arthritis patients: risks and prophylaxis recommendations. Clin Med Insights Circ Respir Pulm Med. 2015;9:29–40.

PubMed  PubMed Central  Google Scholar 

Alanio A, Desoubeaux G, Sarfati C, Hamane S, Bergeron A, Azoulay E, Molina JM, Derouin F, Menotti J. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. Clin Microbiol Infect. 2011;17:1531–7.

Article  CAS  PubMed  Google Scholar 

Dichtl K, Seybold U, Wagener J. Evaluation of a turbidimetric β-d-glucan test for detection of Pneumocystis jirovecii pneumonia. J Clin Microbiol. 2018;56:e00286-e318.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Engsbro AL, Najat S, Jørgensen KM, Kurtzhals JAL, Arendrup MC. Diagnostic accuracy of the 1,3-β-D-glucan test for pneumocystis pneumonia in a tertiary university hospital in Denmark: a retrospective study. Med Mycol. 2019;57:710–7.

Article  CAS  PubMed  Google Scholar 

Del Corpo O, Butler-Laporte G, Sheppard DC, Cheng MP, McDonald EG, Lee TC. Diagnostic accuracy of serum (1–3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis. Clin Microbiol Infect. 2020;26:1137–43.